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1. INTRODUCTION 
Fibronectin, a well characterized adhesive 
glycoprotein of several cell types, is composed of 
discrete functional domains that display affinities 
for and interact with a number of macromolecules. 
Such interactions of fibronectin with several 
molecules at the cell surface could account for its 
reported activities in biological processes uch as 
cellular adhesion, migration, shape formation, em- 
bryonic differentiation and opsonization [l-6]. 
serine residue close to COOH terminus has been 
reported. This study attempts to localize the 
phospho~lation sites on secreted fibronectins 
from human and hamster cells with reference to 
other reported domains on the molecule. 
2. MATERIALS AND METHODS 
2.1. Limited cleavage of badged ~~ro~ectin by 
trypin or chymotrypsin 
Fibronectin is present on the cell surface in an 
elaborate fibrillar network and seems to be exten- 
sively disulfide bonded to itself and other proteins 
[7,8]. The disulfide bonds appear to be important 
in the retention of fibronectin at the surface of 
normal cells [9] and are located near the COOH 
terminus linking the subunits to form the fibronec- 
tin dinner [lo]. In addition, the presence of about 
two free sulfhydryl groups has been reported 
whose positions have have been mapped in the 
COOH-terminal half of fibronectin on fragments 
containing fibrin-binding and cell-binding do- 
mains [ll-161. 
Fibronectin is phosphorylated [10,17-191; the 
phosphorylation of fibronectin seems to be a con- 
served phenomenon and occurs on a limited 
number of serine sites [ 181. On bovine plasma 
flbronectin a single site of phosphorylation on the 
NIL 8 hamster cells and human skin fibroblasts 
were grown and labeled as described previously 
[l&20]. Fibronectin from NIL 8 cells was isolated 
by immunopr~ipitation as described in detail [ 18]. 
Fibron~tin from the medium of the GM0977 cell 
line was isolated by affinity chromatography on a 
gelatin-Sepharose column [21] or by immuno- 
precipitation with the monoclonal antibody de- 
scribed according to [22]. Fibronectin present in 
the immune complex was treated with 1 cg/ml 
trypsin or ch~ot~sin [18] for different time 
periods (see figure legends) and the reaction was 
stopped by the addition of 50-fold excess of soy- 
bean trypsin inhibitor or 2 mM PMSF, respective- 
ly. The samples were dissolved by boiling in elec- 
trophoresis sample buffer (50 mM Tris HQ, pH 
6.7,2% SDS, 10 mM dithiothreitol, 2 mM PMSF, 
2 mM EDTA and 10% glycerol). In some instances 
the released fragments of proteolytic digestion 
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were analyzed by centrifugation of the digestion 
mixture followed by application of the supernatant 
directly on gels. Samples were analyzed on S-20% 
gradient polyacrylamide gels or on a 20% gel 
under non-reducing or reducing conditions using 
the Laemmli buffer system [23]. The gels were 
dried without staining or fixing as this was ex- 
tremely important to see the low molecular weight 
peptides [l&l. An intensifying screen was used for 
detection of 32P-radioactivity by autoradiography. 
2.2. Peptide mapping 
32P-labeled ibronectin was released from the 
immune f campex by raising the pH to 12. The 
precipitate was centrifuged and the supernatant 
containing highly purified “P-labeled intact 
fibronectin was neutralized. Extensive digestion 
with trypsin or chymotrypsin was then carried out 
followed by two-dimensional analysis of the en- 
zyme digests as described in detail [18] with one 
modification. The oxidation of fibronectin with 
performic acid was omitted. 
Peptide mapping of the 4 kDa phosphopeptides 
released by limited cleavage with 1 pg/ml of tryp- 
sin or chymotrypain utilized the supernatant 
removed after 30 min or 10 min of digestion of the 
second immune complex respectively. The exten- 
sive digestion with trypsin or chymotrypsin was 
then performed as described above for intact 
fibronectin. 
2.3. Labeling of &one&n with iodapn/acetic 
acid 
32P-labeled GM 0077 fibronectin was purified by 
affinity chromatography, peak fractions eluted 
with 4 M urea were pooled and reacted with iodo- 
[3H]acetic acid (1 mCi/ml) for 90 mm in the dark 
at 37’C. The unreacted iodol’H]acetic acid and 
urea were dialyzed out against several changes of 
phosphate-buffered saline and the fibronectin was 
subjected to trypsin digestion as described above. 
2.4, Separation of 4 kDa phosphopeptides on 
HPLC 
50-100 ,ul of samples of 32P-/iodo[3H]acetic 
acid-labeled 4 kDa phosphopeptides were injected 
into a Waters HPLC system. The column utilized 
for the separation was a Radial Pak C-8 (column 
diameter 8 mm; ,pore size, 1Opm). The column was 
eluted with 0.1 M ammonium carbonate in an in- 
170 
creasing gradient (setting no. 6) of acetonitrile 
(10-759’0). The change in acetonitrile was l%/min. 
The sample was run at 1 ml/min and 1 ml fractions 
were collected. The fractions were mixed with 
Aquasol (NEN) and counted in a Beckman Model 
LS 700 scintillation counter set to count ‘H and 32P 
simultaneously. 
3. RESULTS 
3.1. Digestion of jibronectin with trypsin and 
chymotrypsin 
The kinetics of trypsin (1 pg/ml) digestion of 
secreted fibronectin from NIL 8 cells labeled with 
either [“Slcystine or [32P]orthophosphate is shown 
in fig.1. Along with several other fragments, a 
major 40 kDa fragment appeared during the 
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Fig. 1. Kinetics of trypsin digestion of [“Slcystine- or 
[32P]orthophosphate labeled fibronectin. Fibronectin 
was isolated from conditioned medium of NIL 8 cells by 
immunoprecipitation and the immune complex was 
treated with 1 rg/ml of trypsin for various time periods. 
Samples were analyzed on a 5-2Wo SDS-polyacryl- 
amide gel a-d. [“‘S]Cystine-labeled fibronectin. (a) 30 s, 
(b) 2 min, (c) 10 min, (d) 30 min. e-i: “P-labeled 
fibronectin. (e) intact fibronectin, (f) 30 s, (g) 2 min, (h) 
10 min, (i) 30 min. The positions of fibronectin (FN), 
40 kDa and 4 kDa fragments are shown. The 40 kDa 
fragment runs slightly ahead of ovalbumin (Mr = 
43000) and the 40 kDa fragment runs slightly slower 
than insulin (MT = 3000). 
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course of digestion of {3sS~cystine-labeled fibro- 
nectin (fig. 1, lanes b and c). Its level was somewhat 
decreased after 30 min of treatment with trypsin 
(fig.1, lane d). There was also an increased ac- 
cum~ation of two small peptides of around 4000 
Da with increasing time periods of trypsin diges- 
tion (fig-l, lanes b, c and d). Si~larly, a major 
40 kDa phospho~ptide and a low molecular mass 
peptide around 4 kDa were generated very early 
during the digestion (30 s -, fig. 1, lane f; and 2 min 
- fig.1, lane g). The high molecular mass, tryptic 
digest intermediates lacking the interchain disul- 
fide bonds reported by Ledger and Tanzer [19] 
were nevet observed in this study. After 10 min of 
treatmeni with trypsin, the 4 kDa phosphopeptide 
abcde 
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Fig. 2. Limited trypsin and ch~o~s~ digestion of 
32P-labekd fibronectin. Fibronecdn was isolated from 
the conditioned medium of NIL g cells by immunopre- 
cipitation and the immune complex was treated with 1 
&g/ml trypsin for 30 min (b,e) or with 1 tg/ml chymo- 
trypsin for 10 min (c,d). Samples were analyzed on a 
540% SDS-polyacrylamide gel. (a) intact fibronectin; 
(b,c) samples were boiled in electrophoresis ample buf- 
fer as usual; (d,e) supernatants of the digestion mixtures 
were directly applied on gel (see Experimental Pro- 
cedures). 
accounted for most of the 32P-label, app~ently at 
the expense of 40 kDa phosph~tide which was 
present only at a much reduced level (fig. 1, lane h). 
Treatment of fibronectin for 30 min with 1 @g/ml 
trypsin released virtually all of the jzP ra~oacti~ty 
in the form of a 4 kDa peptide (fig. 1, lane i). How- 
ever, from this experiment one cannot exclude the 
presence of more than one ph~pho~~de species 
in the 4 kDa band (see below, fig.2 and 4). 
In a second experiment fibronectin was treated 
with trypsin (1 &ml) for 30 min or with chymo- 
trypsin (1 pg/ml) for 10 min. Fig.2, lane b shows 
that treatmeut with trypsin gave rise to a band at 
the 4000 Da position, as in the previoits experi- 
ment. Chymotryptic digestion generated a closely 
spaced doublet (fig.2, lane c). It is difficult to 
assign precise molecular mass in the high percen- 
tage region of the gradient gel, therefore, the two 
closely migrating bands were both designated as 
4 kDa phosphopeptides. In the course of the tryp- 
sin digestion of 32P-labeled fibronectin from NIL 
8 cells immunoprecipitated with polyclonal anti- 
bodies it was also noticed that the 40 kDa phos- 
phopeptide remained attached to the immune com- 
plex (data not shown), whereas the 4 kDa phos- 
phopeptides generated by both chymotrypsin and 
trypsin digestion were released from the immune 
complex (fig.2, lanes d and e). 
Fig.3 shows the two dime~ion~ tryptic and 
chaotic maps of intact 32P-labeled fibronec- 
tin and th 4 kDa phospho~tid~ released by 
limited trypsin and chymotrypsin digestions, 
respectively. The maps generated by trypsin diges- 
tion of both the 4 kDa ph~h~epti~ and intact 
fibronectin had four major spots and were iden- 
tical (fig.3A and B). 
The ch~ot~ti~ maps of intact 32P-labeled 
fibronectin and the 4 kDa phospho~ptid~ are 
shown in fig.3C and D. Each map had the same 
five spots. Spot 2. was always the major spot, 
whereas the inteusity of spot 1 varied in the two 
maps. 
It is clear from the 2D maps that all the “P- 
radioactivity was present in the form of 4 kDa 
phosphopeptides and ,none was lost as very low 
molecular mass peptides. 
131 
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Fig. 3. Two-dimensional tryptic and chymotryptic maps 
of 4 kDa phosphopeptides and intact fibronectin: Tryp- 
tic digests of4 kDa phosphopeptides (A) and 32P-labeied 
intact fibronectin (B), and chymotryptic digests of 
4 kDa phosphopeptide (C) and intact fibronectin (D) 
were analyzed by electrophoresis in 30% formic acid 
toward the cathode in the first dimension and chromato- 
graphy in butyl alcohol/acetic acid/water/pyridine 
(60: 12 : 48 : 40) in the second dimension. 
3.3. Gelatin-binding activity of phosphopeptides 
The 40 kDa and. 4 kDa fragments obtained as 
major phosphopeptides following the trypsin (1 
pg/ml) digestion of 32P-labeled secreted flbronec- 
tin from NIL 8 cells for 2 ruin and 30 ruin respec- 
tively were passed through gelatin Sepharose af- 
finity columns. Fig.4 shows that both fragments 
did not bind to gelatin and were recovered in the 
eluate. 
3.4. Presence of free sul@zydryl and/or disulfde 
groups on the 4 kDa phosphopeptide 
Incorporation of [35S]cystine in the 40 kDa and 
4 kDa fragments of fibronectin indicated the pre- 
sence of free sulfhydryl and/or disulfide groups. 
The following experiments were designed to ex- 
amine these possibilities. 
172 
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Fig. 4. Gelatin binding activity of phosphopeptides of 
fibronectin from NIL 8 cells. Eluates from gelatin-Se- 
pharose affinity column were run on a S-20% gradient 
gel. (a) 4 kDa phosphopeptide isolated from the super- 
natant of 30 min trypsin digest (see section 2). (b) 
40 kDa phosphopcptide was released from the immuno- 
precipitate after digestion with 1 /rg/ml trypsin for two 
minutes by raising the pII to 12. It was neutralized and 
passed through gelatin-Sepharose column. 
3.4.1. Electrophoretic mobility of phosphopep- 
tides on SDS gels under reducing and non- 
reducing conditions 
The 4 kDa phosphopeptide released from the 
immune complex of NIL 8 cells after 10 min of 
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partial trypsiu digestion was resolved as a closely 
spaced doublet on a 20% gel under reducing condi- 
tions (fig.Sa). However, the supematant of the 
partial tryptic digestion of fibronectin from the 
GM0077 human fibroblast cell line, immunopre- 
cipitated with the monocloual antibody 4B2 
directed against a single antigenic determinant near 
the gelatin-binding site, contained the 4 kDa 
doublet as well as bands in the 40 kDa region and 
the undigested fibronectin (fig5b), both of which 
remain attached to polyclonal antibodies in the im- 
mune complex of fibronectin from NIL 8 cells. In 
repeated experiments multiple bands of Mr = 
40000 were observed in the partial trypsin digest of 
human cellular fibronectin suggesting multiple 
trypsin sensitive sites in that region. Under non- 
reducing conditions the 4 kDa bands migrated 
more slowly and the radioactivity in the 40 kda 
band migrated faster than under reducing condi- 
tions (fig.% and d). 
a b 
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Fig. 5. Electropboretic mobilities of partial trypsin 
digest of 3zP-labeIed fibronectin under reducing and 
nonreducing conditions on a 209’0 SDS-polyacrylamide 
gel. The positions of FN, 40 kDa and 4 kDa fragments 
are marked. (a) NIL 8 cells non-reduced. (b) GM0077 
cells non reduced. (c) GM0077 cells reduced. (d) NIH 8 
cells reduced. 
I II z4 i(* .I . . I. . . I* 
FRACTION NUMBER 
Fig. 6. Separation of the trypsin digest of [32P]ortho- 
phosphate- and iodo[3H]acetic acid-labeled fibronectin 
from GM0077 human tibroblasts on an HPLC column. 
3.4.2. Resolution of [32P]orthophosphate and 
iodo[3H]acetic acid radioactivity on an 
HPLC cohunn 
32P-labeled secreted fibronectin from GM0077 
fibroblast was purified on gelatin-Sepharose col- 
umn, eluted with 4 M urea and reacted with 
iodo[‘H]acetic acid. The free iodo[‘H]acetic acid 
and urea were then dialyzed out and the labeled 
protein was subjected to digestion with trypsin (1 
/rg/ml) for 30 min, a treatment hat released most 
of the 32P-label in the form of 4 kDa peptides. 
Upon injection of the trypsin digest into the HPLC 
column, “P and ‘H counts were eluted in cor- 
responding peaks (fig.6). The broad peak of 3H 
radioactivity represented undialyzed free iodo- 
f3H]acetic acid. 
4. DISCUSSION 
Fibronectin is involved in some of the basic 
cellular functions such as adhesion and locomotion 
([24-271; also see reviews [l-6]). Considering this, 
it is not surprising that fibronectin is a highly con- 
served protein in structure [28]. Phosphorylation 
of fibronectin, which occurs only on serine resi- 
dues, also seems to be a conserved phenomenon as 
the phosphopeptides of fibronectin are shared by 
different species 1181. 
The similarity of the two-dimensional maps of 
fibronectin with those from 4 kDa phosphopep- 
tides demonstrate that fibronectin is phosphor- 
ylated within discrete, protease sensitive, low 
173 
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molecular mass domains. The migration of tryptic 
and chymotryptic phosphopeptides as doublets on 
SDS-polyacrylamide gels (figs.2 and 4) indicate 
that fibronectin from hamster and human cells 
might be phosphorylated at least on two serine 
residues located on two different fragments. 
Furthermore, the resolution of the phosphopep- 
tides of hamster cellular fibronectin in four to five 
spots in two dimensional maps (fig.3) strongly sug- 
gests multiple phosphorylation sites and also 
microheterogeneity in fibronectin molecules due to 
post-translational modifications. A single serine 
residue near the COOH terminus has been re- 
ported to be partially phosphorylated in bovine 
plasma fibronectin [lo]. That one of the sites of 
phosphorylation of hamster and human cellular 
fibronectin might also be near the COOH terminus 
is suggested by two observations. First, the 4 kDa 
phosphopeptide is produced in less than a minute 
of treatment with very low concentrations of tryp- 
sin. It has been demonstrated that a small COOH- 
terminal region of fibronectin (between 3 kDa and 
10 kDa depending on the enzyme and source of 
fibronectin) containing the intermolecular disul- 
fide bonds is readily susceptible to proteolysis 
[16,29-321. Second, in the absence of reducing 
agents at least one of the 4 kDa phosphopeptides 
of fibronectins from both hamster and human cells 
migrate on a 20% SDS-polyacrylamide gel with a 
higher apparent molecular mass (fig.4). 
The coelution of 32P and 3H radioactivities of 
4 kDa phosphopeptides from the fibronectin of 
human fibroblasts after passing through an HPLC 
column (fig.5) shows that a cysteine residue 
available for reaction with iodo[3H]acetic acid is 
located close to the phosphorylation site(s). Sever- 
al studies based upon limited protease digestions, 
cyanide cleavage experiments and recognition of 
sulfhydryl-containing fragments by hybridoma an- 
tibodies propose the location of l-2 moles of free 
sulfhydryl groups/mole of fibronectin monomer 
about 30-70 kDa from the COOH terminus 
[12,13,16,33,34]. The data presented here demon- 
strate that the 40 kDa phosphopeptide which ap- 
pears as a major kinetic intermediate during the 
tryptic digestion of fibronectin displays a slower 
electrophoretic mobility in its reduced state than 
under nom-educing conditions. This indicates that 
the 40 kDa phosphopeptide is constrained by 
intramolecular disulfide bonds. A slower migra- 
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tion under reducing conditions has been reported 
for two fragments of fibronectin, a 25 kDa frag- 
ment near the NH2 terminus 1321 and a 31 kDa 
fragment near the COOH terminus [34]. This is 
consistent with the sequence studies of bovine 
plasma fibronectin demonstrating the presence of 
the disulfide loops in a COON terminal fragment 
[10,35]. The 40 kDa phosphopeptide must origi- 
nate from the COOH-terminal region of fibronec- 
tin containing the disulfide loops as it is not 
located near the gelatin-binding region close to the 
NHz-terminus and does not bind to gelatin. 
The other free sulfhydryl group of fibronectin is 
located on a domain that contains 40% of the car- 
bohydrate and the cell spreading activity [16]. The 
results presented here are suggestive of more than 
one phosphorylation site on fibronectin molecule. 
The likely candidates are serine residues (a) near 
the COOH-terminus and probably within the 
disulfide-bonded fragment, and (b) near the free 
sulfhydryl group located in the fibrin-binding do- 
main and/or in the fragment containing the cell at- 
tachment site. 
It is tempting to speculate that yet another 
potential site of phosphorylation exists on the 
serine residue of the tetrapeptide Arg-Gly-Asp-Ser 
that carries the cell-attachment promoting activity 
of fibronectin [36]. It would be interesting to in- 
vestigate the effect of phosphorylation of serine 
residue on the activity of this tetrapeptide, espe- 
cially in the light of findings that phosphorylation 
occurs to a much greater extent on fibronectins 
from transformed and rapidly growing cells 
[18,20]. More definite information on the precise 
location and function of the phosphorylation sites 
on fibronectin will come from sequence studies 
and by use of defined hybridoma antibodies. 
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